Clinical Trial Update: Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial using PET to study occupancy of dopamine D3 receptors by buspirone in humans, in the context of smoking cessation research.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Buspirone (buspirone)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Smoking Cessation, Tobacco Use Cessation | Phase 1, Phase 2 | Status: COMPLETED